Charles River Laboratories International (CRL) Deferred Taxes (2009 - 2025)

Charles River Laboratories International's Deferred Taxes history runs 17 years deep, the most recent figure standing at -$60.2 million for Q4 2025.

• In Q4 2025, Deferred Taxes fell 45.2% year-over-year to -$60.2 million; the TTM figure through Dec 2025 stood at -$75.3 million (down 11.66% YoY), while the FY2025 annual figure was -$75.3 million, down 11.66% from the prior year.
• Deferred Taxes for Q4 2025 stood at -$60.2 million, down from $25.9 million in the prior quarter.
• The five-year high for Deferred Taxes was $25.9 million in Q3 2025, with the low at -$60.2 million in Q4 2025.
• The 5-year median for Deferred Taxes is -$11.6 million (2022), against an average of -$12.7 million.
• The sharpest annual moves came in 2021 and 2025: Deferred Taxes surged 477.25% in 2021, then slumped 1829.18% in 2025.
• Charles River Laboratories International's Deferred Taxes stood at -$10.2 million in 2021, then gained by 6.71% to -$9.6 million in 2022, then sank by 136.92% to -$22.7 million in 2023, then sank by 82.94% to -$41.4 million in 2024, then plunged by 45.2% to -$60.2 million in 2025.
• Business Quant data shows CRL's Deferred Taxes at -$60.2 million in Q4 2025, $25.9 million in Q3 2025, and -$22.0 million in Q2 2025.